Endocrine-disease-focused Visen Pharmaceuticals is making its public market debut in Hong Kong, filing papers for an $86.5 ...
News-Medical.Net on MSN1d
Fatty liver disease linked to higher mortality risk from many common diseasesA comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality ...
IceCure Medical (ICCM) announced it is in continued discussions with the U.S. FDA regarding its De Novo marketing authorization request for ...
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
News-Medical.Net on MSN5d
Mediterranean diet shows promise in easing psoriasis, acne, and hidradenitis suppurativaA recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...
John Amos, Dr. Farhad Zangeneh, Medical Director of Endocrine, Diabetes and Osteoporosis Clinic, Dr. Dina Peralta-Reich, New York Weight Wellness Medicine Founder and Director, and Peter Maher, a ...
Matthew Frederick Nobiesse Laboratories, LLC +1 917-224-8124 email us here Visit us on social media: Facebook X LinkedIn Instagram YouTube TikTok Legal Disclaimer: ...
PR Newswire CAESAREA, Israel IceCure working in close collaboration with FDA towards De Novo decision CAESAREA, Israel /PRNewswire/ -- IceCure Medi ...
Nobiesse introduces a Deodorant Sampler Bundle, offering aluminum-free, fragrance-free options to meet the growing demand for non-toxic skincare. Matthew Frederick Nobiesse Laboratories, LLC +1 ...
The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.
AZoRobotics on MSN6d
Forget Ozempic—This AI-Found Peptide May Be the Future of Weight LossThe identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback